MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.
Stahlhut, Carlos, and Frank J Slack. 2013. “MicroRNAs and the Cancer Phenotype: Profiling, Signatures and Clinical Implications.”. Genome Medicine 5 (12): 111.
Search
Search results
13389 results found
Small RNAs deliver a blow to ovarian cancer.
Kasinski, Andrea, and Frank J Slack. 2013. “Small RNAs Deliver a Blow to Ovarian Cancer.”. Cancer Discovery 3 (11): 1220-1.
Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.
Chen, Xiaowei, Frank J Slack, and Hongyu Zhao. 2013. “Joint Analysis of Expression Profiles from Multiple Cancers Improves the Identification of MicroRNA-Gene Interactions.”. Bioinformatics (Oxford, England) 29 (17): 2137-45.
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC.
Kasinski, Andrea L, and Frank J Slack. 2012. “Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic MiR-221 in HCC.”. Molecular Therapy. Nucleic Acids 1 (3): e12.
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.
Babar, Imran A, Christopher J Cheng, Carmen J Booth, Xianping Liang, Joanne B Weidhaas, Mark Saltzman, and Frank J Slack. 2012. “Nanoparticle-Based Therapy in an in Vivo MicroRNA-155 (miR-155)-Dependent Mouse Model of Lymphoma.”. Proceedings of the National Academy of Sciences of the United States of America 109 (26): E1695-704.
Biases and errors on allele frequency estimation and disease association tests of next-generation sequencing of pooled samples.
Chen, Xiaowei, Jennifer B Listman, Frank J Slack, Joel Gelernter, and Hongyu Zhao. 2012. “Biases and Errors on Allele Frequency Estimation and Disease Association Tests of Next-Generation Sequencing of Pooled Samples.”. Genetic Epidemiology 36 (6): 549-60.
The duality of oncomiR addiction in the maintenance and treatment of cancer.
Cheng, Christopher J, and Frank J Slack. 2012. “The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer.”. Cancer Journal (Sudbury, Mass.) 18 (3): 232-7.
MicroRNA predictors of longevity in Caenorhabditis elegans.
Pincus, Zachary, Thalyana Smith-Vikos, and Frank J Slack. 2011. “MicroRNA Predictors of Longevity in Caenorhabditis Elegans.”. PLoS Genetics 7 (9): e1002306.
MicroRNA signatures differentiate melanoma subtypes.
Chan, Elcie, Rajeshvari Patel, Sunitha Nallur, Elena Ratner, Antonella Bacchiocchi, Kathleen Hoyt, Sebastian Szpakowski, et al. 2011. “MicroRNA Signatures Differentiate Melanoma Subtypes.”. Cell Cycle (Georgetown, Tex.) 10 (11): 1845-52.
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
Ratner, Elena, Lingeng Lu, Marta Boeke, Rachel Barnett, Sunitha Nallur, Lena J Chin, Cory Pelletier, et al. 2010. “A KRAS-Variant in Ovarian Cancer Acts As a Genetic Marker of Cancer Risk.”. Cancer Research 70 (16): 6509-15.